Will the HVTN 702 (Uhambo) study result in a successful vacine against AIDS?

>>

About this question

A large trial for a vaccine against the HIV virus, which is responsible for AIDS, started in South Africa in late 2016. The study is officially called HVTN 702, or Uhambo.

The vaccine requires 5 injections within a year, then researchers will follow up for the following two years to test whether the vaccine regimen works. Results for the vaccine study are expected by 2020.

If the vaccine meets the 50 percent threshold, it will be considered sucessful and this question will be resolved as "Yes".

Analysing
100806040200Nov-2018Dec-2018Jan-2019

Latest Bets

User and outcomeSharesPrice
dariobp
Yes
100.74ø
my3coder2
Yes
26.73ø
FelipeF
No
563
sold
.34ø
LuigiFabozzi
Yes
100.59ø
FCatarim
Yes
658.49ø
View all predictions

Predict
the Future

Futuur is a marketplace for predictions about the future. Sports, politics, entertainment, finance, everything! Show your knowledge and try to to be the best forecaster in the world!